Research Library

David R. Brockman and Edward M. Emmett discuss three high-profile bills introduced by Texas lawmakers in 2023 and their connection to a broader movement that seeks to privilege Christianity in public schools.

Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.

Information and cyber action have been important but ancillary components of the Ukraine war since its outbreak on February 24, 2022. We offer a set of observations:

In the wake of the collapse of Terra — a once-prosperous blockchain network that suffered one of the biggest falls in the history of cryptocurrency — the authors discuss recent government efforts to regulate digital assets.

Senior fellow Neal Lane remembers colleague Robert F. Curl.

Scenes of insurrectionists rummaging through offices and computers in the Capitol highlight the urgent need for Congress to up its IT security game. The authors recommend steps to adopt modern IT management and cybersecurity processes that are already used throughout the federal government.

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.